Top compounds associated with response to RNF181


Feature Type Standardized
Nominal ANOVA
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.24 2e-13
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.2 4e-12
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.19 5e-11
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.21 1e-10
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.21 1e-10
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.19 2e-10
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 4e-09
mRNA GSK1070916 GDSC1000 pan-cancer AAC -0.18 5e-09
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 1e-08
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.19 1e-08
Download CSV